2026 MIND Prize
The MIND Prize funds bold, innovative neuroscience research by early-to-mid-career scientists to advance understanding and treatment of neurodegenerative diseases.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026 (Letter of Intent deadline, projected)
Funding Amounts: $750,000 total over 3 years ($250,000/year; max 10% indirect costs included)
Summary: Supports innovative, high-impact neuroscience research by early-to-mid-career investigators to advance understanding and treatment of neurodegenerative diseases.
Key Information: Forecasted opportunity—dates and details may shift; check program page for updates.
Description
The MIND Prize, offered by Pershing Square Philanthropies, is designed to catalyze transformative research in neuroscience, with a focus on understanding, predicting, preventing, and treating neurodegenerative diseases such as Alzheimer’s Disease and Dementia. This prize targets early-to-mid-career investigators leading bold, high-risk, high-reward projects that challenge conventional paradigms and foster interdisciplinary collaboration. Projects may involve novel tools, technologies, and innovative therapeutic approaches for brain mapping or disease intervention. Awardees join a vibrant network of researchers and gain access to mentorship, networking events, and opportunities for increased visibility within the neuroscience community.
